Impact of Envarsus XR on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

Grants and Contracts Details

StatusActive
Effective start/end date11/6/172/7/23

Funding

  • Veloxis Pharmaceuticals Incorporated: $163,869.00